Björn Magnus Sjöstrand
Chairman presso SPRINT BIOSCIENCE AB
Patrimonio netto: 649 451 $ in data 31/03/2024
Profilo
Björn Magnus Sjöstrand is the founder of Unitech Pharma AB (founded in 2010) and Scandinavian Biopharma Holding AB (founded in 2010).
He held the title of Chief Executive Officer at Unitech Pharma AB from 2010 to 2011.
Currently, Mr. Sjöstrand is the Chief Executive Officer & Director of Björn Sjöstrand Konsult AB, Chairman of Intervacc AB (since 2018), Chairman of Sprint Bioscience AB (since 2021), and Director of B&M Sjöstrand AB and Sjoestrand Biobusiness AB.
In his former positions, he served as the Chief Executive Officer of Berna Biotech AG from 2007 to 2009, President & Chief Executive Officer of SBL Vaccin AB from 2002 to 2007, Chairman of Modus Therapeutics AB and Modus Therapeutics Holding AB, Director of Eurocine Vaccines AB and European Vaccine Manufacturers, Global Head-Vaccines Division at Crucell NV from 2007 to 2009, and Vice President-Operations & Information Technology at Active Biotech AB.
He was also a Member of GAVI Alliance (United States).
Mr. Sjöstrand obtained his undergraduate degree from Orebro University.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
INTERVACC AB
2.48% | 30/06/2023 | 1 876 862 ( 2.48% ) | 649 451 $ | 31/03/2024 |
Posizioni attive di Björn Magnus Sjöstrand
| Società | Posizione | Inizio |
|---|---|---|
| INTERVACC AB | Chairman | 14/06/2018 |
| SPRINT BIOSCIENCE AB | Chairman | 01/01/2021 |
| Scandinavian Biopharma Holding AB | Chief Executive Officer | 01/02/2010 |
| B&M Sjöstrand AB | Director/Board Member | - |
| Björn Sjöstrand Konsult AB | Chief Executive Officer | - |
| Sjoestrand Biobusiness AB | Director/Board Member | - |
Precedenti posizioni note di Björn Magnus Sjöstrand
| Società | Posizione | Fine |
|---|---|---|
Unitech Pharma AB
 Unitech Pharma AB Pharmaceuticals: MajorHealth Technology Unitech Pharma is a full service contract manufacturer with flexible state of the art facilities. The firm has more than 20 years experience in bio production and provides contract manufacturing services for products used in clinical trials and for commercial sale. Its customers represent both international pharmaceutical companies along with small and mid-sized biotech companies. The company has invested in a state-of-the-art, flexible bio production and fill and finish facility licensed by EMEA. In the pharmaceutical area, medicines are filled in single-use syringes or injection vials while meeting rigorous sterility requirements in accordance with aseptic manufacturing procedures. The firm also offers freeze drying, by combining its capabilities in Matfors with its experienced staff at the Stockholm based development hub Unitech Pharma can offer customers a truly full-service solution for pharmaceutical manufacture including process development. | Chief Executive Officer | 01/01/2011 |
Crucell NV
 Crucell NV Pharmaceuticals: MajorHealth Technology Crucell NV develops, produces and markets vaccines, proteins and antibodies that prevent and treat infectious diseases. It focuses in the research & development of innovative immunization candidates to fight against tuberculosis, malaria, HIV/AIDS, influenza, rabies, polio and several other diseases which are the global health problems. The firms prod8ucts include Quinvaxem, Epaxal, Hepavax-Gene, Vivotif and Dukoral against paediatric, respiratory and travel or endemic infections. The company was founded by Domenico Valerio on October 9, 2000 and is headquartered in Leiden, Netherlands. | Corporate Officer/Principal | 01/10/2009 |
Berna Biotech AG
 Berna Biotech AG Miscellaneous Commercial ServicesCommercial Services Berna Biotech AG produced and developed immunobiological preparations. It offered respiratory, hepatitis B, pediatric, veterinary and travel vaccines. The company was founded in 1898 and was headquartered in Bern, Switzerland | Chief Executive Officer | 01/01/2009 |
| ░░░ ░░░░░░ ░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░ ░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | - |
Formazione di Björn Magnus Sjöstrand
| Orebro University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 5 |
|---|---|
| EUROCINE VACCINES AB | Health Technology |
| ACTIVE BIOTECH AB | Health Technology |
| INTERVACC AB | Health Technology |
| SPRINT BIOSCIENCE AB | Health Technology |
| MODUS THERAPEUTICS HOLDING AB | Health Technology |
| Aziende private | 11 |
|---|---|
Crucell NV
Crucell NV Pharmaceuticals: MajorHealth Technology Crucell NV develops, produces and markets vaccines, proteins and antibodies that prevent and treat infectious diseases. It focuses in the research & development of innovative immunization candidates to fight against tuberculosis, malaria, HIV/AIDS, influenza, rabies, polio and several other diseases which are the global health problems. The firms prod8ucts include Quinvaxem, Epaxal, Hepavax-Gene, Vivotif and Dukoral against paediatric, respiratory and travel or endemic infections. The company was founded by Domenico Valerio on October 9, 2000 and is headquartered in Leiden, Netherlands. | Health Technology |
Berna Biotech AG
Berna Biotech AG Miscellaneous Commercial ServicesCommercial Services Berna Biotech AG produced and developed immunobiological preparations. It offered respiratory, hepatitis B, pediatric, veterinary and travel vaccines. The company was founded in 1898 and was headquartered in Bern, Switzerland | Commercial Services |
SBL Vaccin AB
 SBL Vaccin AB Pharmaceuticals: MajorHealth Technology SBL Vaccin AB manufactures and distributes vaccines. Its products are used for the treatment of polio, diarrhoea, and cholera diseases. The company distributes products to the healthcare centers, hospitals, schools, and industrial healthcare units. SBL Vaccin was founded in 1957 and is located in Solna, Sweden. | Health Technology |
| European Vaccine Manufacturers | |
| GAVI Alliance (United States) | Miscellaneous |
Unitech Pharma AB
Unitech Pharma AB Pharmaceuticals: MajorHealth Technology Unitech Pharma is a full service contract manufacturer with flexible state of the art facilities. The firm has more than 20 years experience in bio production and provides contract manufacturing services for products used in clinical trials and for commercial sale. Its customers represent both international pharmaceutical companies along with small and mid-sized biotech companies. The company has invested in a state-of-the-art, flexible bio production and fill and finish facility licensed by EMEA. In the pharmaceutical area, medicines are filled in single-use syringes or injection vials while meeting rigorous sterility requirements in accordance with aseptic manufacturing procedures. The firm also offers freeze drying, by combining its capabilities in Matfors with its experienced staff at the Stockholm based development hub Unitech Pharma can offer customers a truly full-service solution for pharmaceutical manufacture including process development. | Health Technology |
Modus Therapeutics AB
 Modus Therapeutics AB Pharmaceuticals: MajorHealth Technology Modus Therapeutics AB operates as a clinical-stage drug development company that develops new pharmaceutical therapies designed to restore impaired blood flow and oxygen transport in diseases with unmet medical needs. The firm’s product Sevuparin, evaluates in a phase II clinical trial in sickle cell disease (SCD) and repeated painful crises in SCD, so called vaso-occlusive crises (VOC) that leads to loss of vital organ function and reduced life span. The company was founded by Carl Mats Wahlgren in 2011 and is headquartered in Solna, Sweden. | Health Technology |
| Scandinavian Biopharma Holding AB | |
| Björn Sjöstrand Konsult AB | |
| B&M Sjöstrand AB | |
| Sjoestrand Biobusiness AB |
- Borsa valori
- Insiders
- Björn Magnus Sjöstrand
